OvuGel

RSS

Triptorelin

Authorised
This medicine is authorised for use in the European Union.

Overview

OvuGel is a veterinary medicine used to synchronise ovulation in weaned sows (sows whose piglets have been taken away) for reproduction to enable artificial insemination. Because ovulation occurs as a timed response to treatment with Ovugel, a timed insemination program can therefore be used to breed sows.

OvuGel contains the active substance triptorelin (as acetate), which is a synthetic analogue of gonadotropin releasing hormone (GnRH).

This EPAR was last updated on 07/05/2021

Authorisation details

Product details
Name
OvuGel
Agency product number
EMEA/V/C/005219
Active substance
Triptorelin acetate
International non-proprietary name (INN) or common name
Triptorelin
Species
Pigs (sows for reproduction)
Anatomical therapeutic chemical veterinary (ATCvet) codes
QH01CA97
Publication details
Marketing-authorisation holder
Vetoquinol
Date of issue of marketing authorisation valid throughout the European Union
10/11/2020
Contact address

Magny Vernois 70200
Lure
France

Product information

10/11/2020 OvuGel - EMEA/V/C/005219 -

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Pituitary and hypothalamic hormones and analogues

Therapeutic indication

For the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.

Assessment history

How useful was this page?

Add your rating